# Tendinopathy: Pathophysiology and Current Management

## Introduction

Tendinopathy is one of the most common musculoskeletal conditions encountered in orthopedic practice, accounting for up to 30% of all musculoskeletal consultations. The term **tendinopathy** encompasses a spectrum of tendon disorders characterized by pain, swelling, and impaired function, without implying a specific pathologic mechanism. Understanding the distinction between tendinosis, tendinitis, and paratenonitis is critical, as the underlying pathology directly influences treatment selection. This lecture reviews current concepts in tendon biology, the pathophysiology of tendinopathy, and the evidence-based management of these challenging conditions.

## Tendon Biology and Structure

### Normal Tendon Architecture

Tendons are composed primarily of **type I collagen** (85-95% of dry weight), organized in a hierarchical structure. The basic unit is the **collagen fibril**, which bundles into fibers, fascicles, and ultimately the tendon proper. **Tenocytes** are the predominant cell type, arranged in parallel rows between collagen bundles. The **endotenon** surrounds individual fascicles, the **epitenon** envelops the entire tendon, and the **paratenon** provides a gliding surface in tendons without a synovial sheath (such as the Achilles tendon).

### Tendon Blood Supply and Healing

Tendons are relatively **hypovascular** compared to muscle and bone. Blood supply derives from the musculotendinous junction, the osseous insertion, and the mesotenon. **Watershed zones** of poor vascularity predispose to degeneration, such as the zone 2-6 cm proximal to the Achilles insertion and the supraspinatus critical zone. Tendon healing follows an inflammatory, proliferative, and remodeling sequence, but intrinsic healing capacity is limited.

## Pathophysiology of Tendinopathy

### The Failed Healing Response

| Stage | Pathology | Reversibility | Clinical Correlate |
|-------|-----------|---------------|-------------------|
| Reactive tendinopathy | Non-inflammatory proliferative response; thickened tendon | Reversible with load management | Acute overload; new activity |
| Tendon dysrepair | Matrix disorganization; neovascularization | Partially reversible | Chronic overuse; recurrent symptoms |
| Degenerative tendinopathy | Cell death; matrix breakdown; acellularity | Limited reversibility | Chronic pain; risk of rupture |

Historically, tendon pain was attributed to inflammation (**tendinitis**), but histopathologic studies consistently show a **degenerative** process with minimal inflammatory cells. **Tendinosis** is the hallmark finding: disorganized collagen architecture, increased ground substance, neovascularization, and absent inflammatory infiltrate. The **continuum model** described by Cook and Purdam identifies three stages. **Reactive tendinopathy** is a non-inflammatory proliferative response to acute overload that is potentially reversible. **Tendon dysrepair** represents failed healing with increased matrix disorganization and neovascularization. **Degenerative tendinopathy** involves cell death, widespread matrix breakdown, and areas of acellularity with limited reversibility.

### Mechanical and Biological Factors

**Overuse** and repetitive microtrauma are the primary drivers, particularly with abrupt changes in loading volume. Compressive loads at insertions contribute to **insertional tendinopathy** (such as Achilles insertional disease). Biological risk factors include age (decreased tenocyte activity), diabetes, hypercholesterolemia, and obesity. **Fluoroquinolone antibiotics** and systemic corticosteroids increase tendinopathy risk through direct cytotoxic effects on tenocytes. Genetic predisposition has been identified through polymorphisms in collagen genes (COL5A1, MMP3).

![Histologic comparison of normal tendon showing organized parallel collagen fibers versus tendinosis showing disorganized collagen, increased ground substance, and neovascularization](tendinosis-histology-comparison.jpg)

## Clinical Presentation and Diagnosis

### Common Sites of Tendinopathy

The **Achilles tendon** is affected in both midsubstance (2-6 cm from insertion) and insertional variants. The **patellar tendon** develops "jumper's knee," typically at the inferior pole of the patella. The **lateral epicondyle (common extensor origin)** is the site of "tennis elbow," affecting the extensor carpi radialis brevis. The **rotator cuff** most commonly involves the supraspinatus at its critical zone of hypovascularity. The **gluteal tendons** produce greater trochanteric pain syndrome, increasingly recognized as a significant cause of lateral hip pain. The **posterior tibial tendon** causes progressive flatfoot deformity in adults.

### Diagnostic Evaluation

Clinical diagnosis is based on localized pain with palpation, pain with resisted loading, and morning stiffness. **Ultrasound** demonstrates tendon thickening, hypoechoic regions, and neovascularization on Doppler imaging. **MRI** shows increased signal intensity on T2-weighted sequences and is superior for assessing partial tears. The **Victorian Institute of Sport Assessment (VISA)** questionnaires provide validated, site-specific outcome measures (VISA-A for Achilles, VISA-P for patellar tendon).

![Ultrasound image of Achilles tendinopathy demonstrating fusiform thickening and hypoechoic regions within the midsubstance of the tendon](achilles-tendinopathy-ultrasound.jpg)

## Non-Operative Management

### Load Management and Exercise Therapy

**Eccentric exercise** programs are the cornerstone of tendinopathy management; the Alfredson protocol for Achilles tendinopathy demonstrated significant improvements over concentric exercise. **Heavy slow resistance (HSR)** training has shown equivalent outcomes to eccentric protocols with higher patient satisfaction. **Isometric loading** provides short-term pain relief and may be used during the reactive phase. Load modification (not complete rest) is essential, as total unloading leads to further tendon deconditioning. Progression should follow the principle of **progressive tendon loading**: isometric, isotonic, energy storage/release, and sport-specific activities.

### Pharmacologic Therapies

**NSAIDs** provide short-term pain relief but do not address the underlying degenerative pathology. **Corticosteroid injections** offer short-term benefit (4-6 weeks) but are associated with worse long-term outcomes, tendon atrophy, and increased rupture risk. **Glyceryl trinitrate (GTN) patches** may stimulate collagen synthesis through nitric oxide-mediated pathways, though evidence remains mixed. **Platelet-rich plasma (PRP)** has variable evidence by site, with some support for lateral epicondylar tendinopathy but less convincing data for Achilles and patellar tendinopathy.

### Adjunctive Therapies

**Extracorporeal shockwave therapy (ESWT)** has moderate evidence for calcific tendinopathy of the rotator cuff and chronic plantar fasciitis. **Dry needling and percutaneous tenotomy** aim to disrupt degenerative tissue and stimulate a healing response. **Activity modification and biomechanical correction** address contributing factors such as training errors, footwear, and kinetic chain deficits.

## Surgical Management

### Indications for Surgery

Surgery is considered after failure of structured non-operative management for a minimum of **6 months**, when significant tendon tearing or structural compromise is demonstrated on imaging, or when progressive deformity develops (such as posterior tibial tendon dysfunction with flatfoot).

### Surgical Options

**Open debridement** with excision of degenerative tissue is the primary approach; if greater than 50% of the tendon cross-section is involved, augmentation or transfer may be required. **Tendon transfer** options include flexor hallucis longus (FHL) transfer for chronic Achilles tendinopathy and posterior tibial tendon reconstruction. **Minimally invasive techniques** include ultrasound-guided percutaneous tenotomy (TENEX) and arthroscopic debridement of the rotator cuff footprint. Postoperative rehabilitation follows graduated loading principles similar to non-operative protocols.

![Intraoperative photograph showing surgical debridement of degenerative tissue within the Achilles tendon midsubstance](achilles-tendon-debridement-surgery.jpg)

## Key Clinical Pearls

The term **tendinitis** is largely a misnomer, as histopathology consistently reveals degeneration (tendinosis) rather than inflammation, which has direct implications for treatment selection. **Eccentric and heavy slow resistance exercise** programs remain the most effective evidence-based treatment, and patients must be counseled that improvement typically requires 12 weeks of consistent loading. **Corticosteroid injections** should be used cautiously and sparingly, as they provide only short-term relief and are associated with worse long-term outcomes and increased rupture risk. One should always assess for modifiable risk factors including fluoroquinolone use, metabolic conditions (diabetes, hyperlipidemia), and training load errors before initiating treatment.

## References

1. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. *British Journal of Sports Medicine*. 2009;43(6):409-416.
2. Alfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. *American Journal of Sports Medicine*. 1998;26(3):360-366.
3. Scott A, Backman LJ, Speed C. Tendinopathy: update on pathophysiology. *Journal of Orthopaedic & Sports Physical Therapy*. 2015;45(11):833-841.
4. Defined P, Maffulli N. Tendinopathy: treatment and rehabilitation. *Clinics in Sports Medicine*. 2015;34(2):xiii-xiv.